KLF2 and endothelial dysfunction: It has been reported that KLF2 levels were reduced in peripheral monocytes of patients with AS by about 30%, and enhancing KLF2 expression by specific activators mitigated endothelial dysfunction and AS through downregulation of proinflammatory genes.96